BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37732867)

  • 1. Research on maintenance treatment to prevent relapse of psychotic disorders.
    Hui CL
    Psychiatry Res; 2022 Nov; 317():114928. PubMed ID: 37732867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
    Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
    Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
    Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
    CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
    Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
    JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis.
    Kishi T; Ikuta T; Matsui Y; Inada K; Matsuda Y; Mishima K; Iwata N
    Psychol Med; 2019 Apr; 49(5):772-779. PubMed ID: 29909790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.
    Asian Network of Early Psychosis Writing Group
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):737-758. PubMed ID: 35451023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
    Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
    Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective on medication decisions following remission from first-episode psychosis.
    Hui CLM; Lam BST; Lee EHM; Chan SKW; Chang WC; Suen YN; Chen EYH
    Schizophr Res; 2020 Nov; 225():82-89. PubMed ID: 32115314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antipsychotic discontinuation or maintenance on the process of recovery in remitted first-episode psychosis patients - A systematic review and meta-analysis of randomized controlled trials.
    Béchard L; Desmeules C; Bachand L; Huot-Lavoie M; Corbeil O; Anderson E; Brodeur S; LeBlanc A; Demers MF; Lauzier S; Roy MA
    Eur Psychiatry; 2024 Jan; 67(1):e13. PubMed ID: 38250810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
    Hui CLM; Honer WG; Lee EHM; Chang WC; Chan SKW; Chen ESM; Pang EPF; Lui SSY; Chung DWS; Yeung WS; Ng RMK; Lo WTL; Jones PB; Sham P; Chen EYH
    Lancet Psychiatry; 2018 May; 5(5):432-442. PubMed ID: 29551618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review.
    Karson C; Duffy RA; Eramo A; Nylander AG; Offord SJ
    Neuropsychiatr Dis Treat; 2016; 12():57-67. PubMed ID: 26792993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
    Andrade C
    J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatment for patients with a first psychotic episode.
    Sommer IEC; Oomen PP; Hasan A
    Curr Opin Psychiatry; 2019 May; 32(3):147-156. PubMed ID: 30720486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of second-generation antipsychotic discontinuation in first-episode psychosis.
    Miller BJ
    J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting psychotic relapse following randomised discontinuation of paliperidone in individuals with schizophrenia or schizoaffective disorder: an individual participant data analysis.
    Brandt L; Ritter K; Schneider-Thoma J; Siafis S; Montag C; Ayrilmaz H; Bermpohl F; Hasan A; Heinz A; Leucht S; Gutwinski S; Stuke H
    Lancet Psychiatry; 2023 Mar; 10(3):184-196. PubMed ID: 36804071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
    Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
    J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
    Zipursky RB; Menezes NM; Streiner DL
    Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
    Üçok A; Kara İA
    Schizophr Res; 2020 Nov; 225():31-38. PubMed ID: 31653578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.